In a murine model of SLE, CLN-978 treatment led to a reduction in circulating B cells, levels of anti-dsDNA IgG, and IgG deposition in the kidney, indicating a disease-modifying effect in both ...
TipRanks on MSN
Nurix Therapeutics’ NX-2127 Study: A Potential Game-Changer in B-cell Malignancy Treatment
Nurix Therapeutics, Inc. (($NRIX)) announced an update on their ongoing clinical study. Nurix Therapeutics, Inc. is conducting a clinical study ...
Aera Therapeutics Presents Preclinical Data and Announces Nomination of First Development Candidate, AERA-109, a Targeted In Vivo CAR-T Therapy for B Cell-mediated Autoimmune Diseases Preclinical data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback